Officials from unihealth hospitals participated in an analyst and institutional investor meeting on July 14, 2026. The interaction was conducted virtually via Zoom, starting at 12:00 P.M. and concluding at 01:30 P.M. The company confirmed that no unpublished price sensitive information (UPSI) was shared during the session.

The disclosure was made to the National Stock Exchange of India Ltd. in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Deshna Jain, the Company Secretary & Compliance Officer, signed the intimation on July 15, 2026.

Key Details of the Meeting

The company clarified that no investor presentation was distributed during the meeting. Unihealth Hospitals Limited, formerly known as Unihealth Consultancy Limited, is headquartered in Mumbai.

Unihealth Hospitals Limited has launched a dedicated Eye Care and Ophthalmology Department at UMC Victoria Hospital in Kampala, Uganda, successfully completing its first cohort of cataract surgeries. This strategic expansion follows the Board's approval on July 3, 2026, to increase the Company's ownership of Victoria Hospital Limited from 50.00% to 99.81% via a share-swap transaction. The move aims to position the Kampala facility as a full-spectrum regional eye-care hub and drive shareholder value by consolidating economic ownership of a profitable overseas asset while expanding clinical capabilities.

The new department is equipped with dedicated surgical infrastructure, specialized diagnostic equipment, and a trained clinical team to treat conditions ranging from routine vision care to complex surgical interventions. The initial cataract procedures were performed successfully without complications, with all patients reporting improved vision during post-operative review. This development addresses a critical gap in Uganda, where cataracts are a leading cause of preventable blindness and access to specialized surgical services is limited.

Strategic Expansion and Corporate Development

The commissioning of the ophthalmology unit is closely linked to the recent corporate restructuring. On July 3, 2026, the Board approved the acquisition of an additional 49.81% equity stake in Victoria Hospital Limited. Upon completion, Unihealth's shareholding will rise to 99.81%, making it an almost wholly owned subsidiary. Management views the new department as an early, tangible return on this consolidation strategy, as incremental investment in high-margin surgical specialties will accrue almost entirely to the Company.

Planned Clinical Enhancements

The launch of cataract surgery services marks the first phase of a broader plan to develop UMC Victoria Hospital into a leading regional eye care centre. Planned expansions include:

• Phacoemulsification (Phaco) Surgery: Introduction of minimally invasive cataract surgery for faster recovery.
• Retinal Surgery Services: Development of capability to treat diabetic retinopathy and retinal detachment.
• Glaucoma Management: Comprehensive diagnostic and surgical services.
• Paediatric Ophthalmology: Specialized screening and treatment for children.
• Advanced Diagnostic Imaging: Investment in optical coherence tomography (OCT) and fundus imaging.
• Outreach and Screening Camps: Community-based programmes to identify patients early.

Financial Performance

The clinical expansion adds a higher-margin service line to an asset that is already among the Group's most profitable. For FY26, Unihealth Hospitals Limited reported the following consolidated financial results:

East Africa contributed the substantial majority of the consolidated revenue. The Company was listed on NSE Emerge in September 2023.